Annals of Hematology

Article	Citations
Composite diffuse large B-cell and peripheral T-cell lymphoma with T-helper phenotype treated with both rituximab and brentuximab vedotin	56
Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience	52
Real world outcomes of lenalidomide or bortezomib maintenance in patients with multiple myeloma not undergoing stem cell transplantation	48
Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients	47
Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study	46
Prevalence of and risk factors for obstructive sleep apnea in children with sickle cell: a multicentric cross sectional study	42
Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients	38
Telomere shortening in donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation: a case report	35
Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria	33
Total marrow irradiation as part of autologous stem cell transplantation for patients with multiple myeloma	32
Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data	32
Income and education affect prognosis and treatment in symptomatic myeloma	32
Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximab	30
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis	30
Adult Langerhans cell histiocytosis with thyroid gland involvement: clinical presentation, genomic analysis, and outcome	30
Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis	29
Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen	28
Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis	28
High susceptibility of febrile neutropenia in Japanese patients receiving venetoclax plus azacitidine therapy for acute myeloid leukemia	26
Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma	25
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic leukemia–like chemotherapy	24
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials	24
Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation	23
Pyrexia of unknown origin—a rare presentation of disseminated leprosy in the bone marrow	22
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experienc	21

Central nervous system relapse of acute promyelocytic leukemia treated by oral Venetoclax with Azacitidine achieved complete remission	21
Predictive scoring system for distinguishing Stenotrophomonas maltophilia bacteremia from Pseudomonas aeruginosa bacteremia in patients with hematological malignancies	21
Frequency of bacteremia in patients with sickle cell disease: a longitudinal study	20
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration	20
Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine	19
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects	19
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version	19
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis	18
Efficacy and safety-related factors of BTK inhibitors as a bridge to CAR-T therapy in R/R FL	18
Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia	18
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group	18
Trends in outcomes and racial disparities in adult hospitalizations for immune thrombocytopenia over a decade	18
Predictors of health-related quality of life of the patients treated for MM: the first study in the Palestinian healthcare system	17
The prognostic value of controlling nutritional status (CONUT) score–based nomogram on extranodal natural killer/T cell lymphoma patients	17
Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation	17
The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis	17
To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a	17
Does the order of busulfan and cyclophosphamide affect allogeneic stem cell transplantation related liver toxicity?	16
A new case of Bicêtre hemoglobin in an adult male: clinical observations over a period of four years	16
High-flow nasal cannula oxygen in patients with haematological malignancy: a retrospective observational study	15
Efficacy and safety of selinexor-based regimens for relapsed/refractory multiple myeloma: a systematic review of literature	15
TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology, treatment challenges, and upcoming approaches	14
Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database	14
Does the order of busulfan and cyclophosphamide affect allogeneic stem cell transplantation related liver toxicity?	14
Role of brentuximab vedotin plus sirolimus in the treatment of classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder: a case-based review	14
Influence of UGT1A1 promoter polymorphism, α-thalassemia and βs haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort	14
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015	14
Inherited transmission of the CSF3R T618I mutation: a familial report	14
Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients	14
CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma	14
Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia	14
Disseminated Mycobacterium haemophilum infection during alemtuzumab treatment of T-cell prolymphocytic leukemia	13
Successful treatment of hairy cell leukemia variant with obinutuzumab	13
Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation:	13
Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysis	12
A study of the relationship between circulating cytokines (interleukin-2 receptor and tumor necrosis factor receptor 2) and risk of B-cell non-hodgkin lymphoma	12
Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab	12
A Filipino infant with severe neutropenia owing to SRP54 mutations was successfully treated with ethnically mismatched cord blood transplantation from a Japanese cord blood bank	12
Interstitial lung disease presents with varying characteristics in patients with non-Hodgkin lymphoma undergoing rituximab-containing therapies	12
Comment on: Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis	12
Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments	12
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia	12
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management	12
Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma	11
A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia	11
High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China	11
Genetic and clinical characteristics of primary hemophagocytic lymphohistiocytosis in children	11
Analysis of PROC mutations and clinical features in 22 unrelated families with inherited protein C deficiency	11
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis	11
Dawn of a new era of antibody-drug conjugates and bispecific T-cell engagers for treatment of multiple myeloma: a systematic review of literature	11

Hematopoietic cell transplantation for MYSM1 deficiency: not so much an easy task	11
USF2 promotes autophagy and proliferation in chronic lymphocytic leukemia by inhibiting STUB1-induced NFAT5 ubiquitination	11
Re: Arcuri and Americo “Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis”	11
miRNA profile and disease severity in patients with sickle cell anemia	11
Screening for hereditary spherocytosis in daily practice: what is the best algorithm using erythrocyte and reticulocyte parameters?	11
Effectiveness and safety of blinatumomab for pediatric B cell acute lymphoblastic leukemia with Loeffler’s endocarditis	10
Digital thermography and vascular involvement in β-thalassemia intermedia	10
Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate	10
Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients	10
Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study	10
Can we restart the rituximab after remission of rituximab-induced interstitial lung disease in malignant lymphoma?	10
Inherited macrothrombocytopenia due to a novel splice donor site mutation in ITGB3	10
A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration	10
Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study	10
A multicentre trial of intensive immunosuppressive therapy combined with umbilical cord blood for the treatment of severe aplastic anaemia	10
Mass cytometry analysis of B-cell populations in extranodal marginal-zone lymphoma of mucosa-associated lymphoid tissue of the lung	10
The clinical efficacy of a daratumumab-based regimen in relapsed/refractory acute leukemia: a single-center experience	9
Comment on: JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response	9
Prognostic value of hyperlactatemia and lactate clearance in septic patients with hematological malignancies	9
Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review	9
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry	9
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrosp	9
Extramedullary and extranodal manifestations in chronic lymphocytic leukemia – an update	9
Risk and impact of cytomegalovirus infection in lymphoma patients treated with bendamustine	9
MYC-targeted genes predict distant recurrence in patients with ocular adnexal extranodal marginal zone lymphoma	9
Heyde syndrome	9
Advances in the ocular complications after hematopoietic stem cell transplantation	9
The life threat in hematopoietic allogeneic stem cell transplantation - an interview and focus group study on health care professionals’ perspectives	9
The efficacy and safety of ZR2 versus R-CHOP-like for elderly patients with newly diagnosed diffuse large B cell lymphoma: a single-center prospective study in China	9
Very severe aplastic anemia with papillary thyroid carcinoma: treatment with allo-HSCT—a case report and literature review	9
The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma	9
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis	9
The role of therapeutic plasma exchange in plasma cell disorders	9
Circulating tumor DNA assisting lymphoma genetic feature profiling and identification	9
Aspergillus pericardial empyema successfully treated with percutaneous drainage in a patient with invasive pulmonary aspergillosis	9
Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms	9
Frequency, pattern, and associations of renal iron accumulation in sickle/β-thalassemia patients	9
A HNRNPC::RARB variant of acute promyelocytic leukemia with concurrent myeloid sarcoma of the spine	9
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma	8
How I manage anemia related to myelofibrosis and its treatment regimens	8
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601	8
Nomogram for predicting survival of patients with diffuse large B-cell lymphoma	8
Stable responses to danicopan as add-on to ravulizumab in two patients with paroxysmal nocturnal hemoglobinuria	8
Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia	8
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts	8
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma	8
NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia	8
Langerhans cell histiocytosis in adults: a retrospective, single-center case series	8
Rasburicase-induced hemolytic anemia and methemoglobinemia: a systematic review of current reports	8
Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report	8
Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia	8
Left atrial deformation indices in β-thalassemia major patients	8
COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study	8
Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia	8
Differentiation syndrome and coagulation disorder — comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemia	8
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning	8
Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma	8
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia	8
Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib	8
A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia	8
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study	8
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients	8
Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco	8
Could it be VEXAS?	8
CMV infection is a risk factor for hemorrhagic cystitis after hematopoietic stem cell transplantation	8
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network)	8
Risk factors and a prediction model of severe asparaginase-associated pancreatitis in children	7
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy	7
Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India	7
Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma	7
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma	7
A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia	7
Loeys-Dietz syndrome with concomitant aplastic anemia	7
Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection	7
Clinical features and prognostic risk prediction of adult hemophagocytic lymphohistiocytosis: a 9-year retrospective study	7
Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis	7
Angioimmunoblastic T-cell lymphoma harboring a t(8;14)(q24;q11.2)/TCR::MYC translocation that presented with intestinal infiltration	7
A real-world study on the impact of infection load on mortality in multiple myeloma patients in Finland	7
JAK2V617F mutation in patients with β-thalassemia disease: prevalence and clinical characteristics	7
Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6–7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor i	7

Presentation of two new mutations in the 3′untranslated region of the β-globin gene and evaluating the molecular spectrum of thalassemia mutations in the Mediterranean region of Turkey	7
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensi	7
Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France — a cohort study using the French National Healthcare database (SNDS)	7
Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia	7
Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study	7
Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis	7
Temporal trends and outcome of splenectomy in adults with immune thrombocytopenia in the USA	7
Clinicopathological risk factors for prognosis and therapeutic response of primary central nervous system lymphoma in China: a single-center retrospective analysis of 118 cases	7
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study	7
Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia	7
Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids	7
Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL	7
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience	7
Epidemiological features and a survival nomogram for primary lymphoma of the male genital tract	7
Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage	7
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy	7
Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report	7
Study on clinical features of early death in older patients with acute promyelocytic leukemia	7
The application of JAK inhibitors in the peri-transplantation period of hematopoietic stem cell transplantation for myelofibrosis	6
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study	6
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients	6
Impact of different CEBPA mutations on therapeutic outcome in acute myeloid leukemia	6
The role of TMPRSS6 gene polymorphism in iron resistance iron deficiency anaemia (IRIDA): a systematic review	6
Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience	6
De-novo ATR-16 syndrome associated with inherited hemoglobin Evanston causing HbH phenotype: a rare occurrence	6
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis	6
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations	6
Bortezomib elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells	6
Highlights of ophthalmological manifestations in newly diagnosed acute leukemia: a correlation with hematological parameters	6
R2-ISS staging combined with circulating plasma cells improves risk stratification for newly diagnosed multiple myeloma: a single-center real-world study	6
Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study	6
Mutations of epigenetic modifier genes predict poor outcome in adult acute lymphoblastic leukemia	6
Integrated single-cell transcriptome analysis of CD34 + enriched leukemic stem cells revealed intra- and inter-patient transcriptional heterogeneity in pediatric acute myeloid leukemia	6
Does R-EPOCH reduce the incidence of pulmonary embolism in cardiac lymphoma?	6
An adult case of systemic lupus erythematosus and cerebral vasculitis after umbilical cord blood transplantation for acute myeloid leukemia	6
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia	6
ETV6::ABL1 positive myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) with blast crisis treated with flumatinib mesylate	6
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension	6
c-Myc inhibits LAPTM5 expression in B-cell lymphomas	6
Venetoclax combined with decitabine and HAAG regimen: a novel salvage strategy for relapsed/refractory T-cell acute lymphoblastic leukaemia	6
Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia	6
Overexpression of REC8 induces aberrant gamete meiotic division and contributes to AML pathogenesis - a multiplexed microarray analysis and mendelian randomization study	6
Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma	6
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study	6
Investigation of a hemophilia family with one female hemophilia A patient and 12 male hemophilia A patients	6
Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy	6
Stanozolol for the treatment of anemic lower-risk myelodysplastic syndromes without del(5q) after failure of epoetin alfa: findings from a retrospective study	6
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis	6
Improved survival of Burkitt lymphoma/leukemia patients: observations from Poland, 1999–2020	6
Response to Dr. Ying Cui comments	6
Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL	6
Exploring and clinical validation of prognostic significance and therapeutic implications of copper homeostasis-related gene dysregulation in acute myeloid leukemia	6
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma	6
Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy	6
Disappearance of a chromosomal abnormality in a young patient with polycythemia vera treated with ropeginterferon alfa-2b	6
COVID-19 outcomes among patients with sickle cell disease or sickle cell trait compared to the general population: a systematic review and meta-analyses	5
Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region	5
Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting	5
PEG-rhG-CSF versus rhG-CSF in supporting neutrophil recovery after induction chemotherapy for patients with newly diagnosed acute lymphoblastic leukemia	5
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience	5
Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005–2016	5
M1 macrophage-derived exosomes alleviate leukemia by causing mitochondrial dysfunction	5
The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease	5
Early prediction of platelet recovery with immature platelet fraction in patients receiving hematopoietic stem cell transplantation	5
DNMT3A-R882: a mutation with many paradoxes	5
Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation	5
Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia	5
Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemia	5
Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis	5
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzum	5
The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction	5
Generic ibrutinib a potential cost-effective strategy for the first-line treatment of chronic lymphocytic leukaemia	5
A prognostic index for advanced-stage extranodal natural killer/T-cell lymphoma: A multicenter study	5
Integrated metabolomic and microbiome analysis identifies Cupriavidus metallidurans as a potential therapeutic target for β-thalassemia	5
Circulating monocytes decrease significantly following disease-directed therapy and may reflect disease expansion in Langerhans Cell Histiocytosis	5
Severe aplastic anemia with acquired X chromosome clonality as a sole abnormality	5
Pregnancy outcome in women with transfused beta-thalassemia in France	5
Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia	5
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants	5
Acute myeloid leukemia with rare recurring translocations—an overview of the entities included in the international consensus classification	5
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study	5
Application of allogeneic hematopoietic stem cell transplantation to treat Behcet’s disease with myelodysplastic syndrome: a case report and literature review	5
Adipopenia is associated with poor outcomes in elderly patients with B-cell lymphoma	5
Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement	5
Novel serous effusion-related risk models and biomarkers for predicting prognosis in T-cell lymphoma patients	5
Prognosis of aggressive adult T-cell leukemia/lymphoma with central nervous system infiltration and utility of CD7 versus CADM1 flowcytometric plots of cerebrospinal fluid	5
Therapy-related myeloid neoplasms: a real-world pharmacovigilance analysis (1970–2023)	5
Treatment outcomes between cyclosporin and chemotherapy in adult subcutaneous panniculitis-like T-cell lymphoma: a report from nation-wide Thai lymphoma study group registry	5
Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche	5
First clinical and pedigree study of rare HBB: c.316–90 A > G variant in β-globin gene in Chinese population using third-generation sequencing	5
Development and validation of prognostic models based on 18F-FDG PET radiomics, metabolic parameters, and clinical factors for elderly DLBCL patients	5
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma	5
MDS patient registries - achievements and challenges	5
Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis	5
Diagnosis and management of non-clonal erythrocytosis remains challenging: a single centre clinical experience	5